Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Actor and comedian Eric Idle revealed the last conversation he had with his friend Rob Reiner, just hours before the director’s death. The Monty Python star, 82, divulged that he shared a long phone ...

Eric Idle today revealed he spoke with Rob Reiner in the hours before his 'lovely' friend was found dead with his wife in their LA mansion. The British Monty Python star, 82, has said they had made ...

As the world prepares for the holiday season, a time when families gather and work pauses, JDH AI is ensuring that technology keeps working. Today, the platform announces a major global expansion of ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

CLEVELAND, Ohio -- Fifty years after “Monty Python and the Holy Grail,” Eric Idle never thought he’d still be talking about the cult classic film, much less a musical inspired by it. But here we are, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

I tried running the same program on IDLE with the same Python version (3.10.11) and it produced a RecursionError normally, so it seems possible that there's something happening in Thonny that's ...

Audiences can still look forward to hearing the tour’s namesake song, “Always Look on the Bright Side of Life,” from Monty Python’s Life of Brian. And Idle noted that he’s especially gratified to hear ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...